Department of Bioengineering and Therapeutic Sciences

Postdoctoral fellowship applications for Health Innovation via Engineering

Tue Feb 23, 2021
two scientists in laboratory
Susan Merrell

Health Innovation via Engineering (HIVE) scientists in laboratory

A one-year Fellowship within HIVE seeks to inspire and encourage bioengineers to address grand challenges of health care.

UCSF School of Pharmacy leads in NIH funding for the 41st straight year

Thu Feb 18, 2021
Burchard
Steve Babuljak

Esteban Burchard, MD, MPH

Over $40 million in 2020 NIH funding to the School supported research ranging from the genomics of asthma to new malaria treatments

A universal mechanism for activation of MST2 during Hippo signal transduction: a QBI online seminar with Jennifer Kavran

Wed Feb 17, 2021
Kavran.
The QBI Online Seminar Series is presenting Jennifer Kavran, an assistant professor of Biochemistry and Molecular Biology at the Bloomberg School of Public Health at Johns Hopkins University. Dr. Kavran's lab is focused on understanding the regulation of the Hippo core kinase cassette using a...

Transcription factor binding to DNA mismatches – a potential driver of increased mutagenesis at regulatory sites: a QBI online seminar with Raluca Gordan

Wed Feb 17, 2021
Gordan.
The QBI Online Seminar Series is presenting Raluca Gordan, an associate professor in the Center for Genomic and Computational Biology at Duke University. She received her PhD degree from Duke University in 2009, followed by postdoctoral training at the Harvard Medical School.

Pharmacy community lends hand to UCSF COVID-19 vaccine effort

Wed Feb 10, 2021
Aludino and employee record dose of vaccine
Susan Merrell

UCSF pharmacy student Matthew Aludino, right, scans a dose of the Pfizer COVID-19 vaccine prior to administering it on the first day of vaccinations at UCSF, December 16, 2020.

Pharmacy students, technicians, faculty members, and providers all pitched in to the rollout of the COVID-19 vaccine.

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics: a QBI online seminar with Craig Markin

Wed Feb 3, 2021
Markin.
Craig Markin is a postdoctoral fellow working jointly with Professors Dan Herschlag and Polly Fordyce at Stanford University, where he has developed HT-MEK (High-Throughput Microfluidic Enzyme Kinetics), a novel microfluidics-based assay to express, purify, and quantitatively measure libraries of...

Synthetic biomaterial guides cancer therapy to hidden tumors

Wed Jan 20, 2021
DNA double helix

Tejal Desai, PhD, and colleagues took inspiration from the structure of DNA to engineer a biomaterial that promises to improve CAR-T cell therapy for various cancers.

Advance opens up new possibilities for CAR T-cell therapy to treat a variety of cancers

Dissecting Viruses: From Cell Circuits to First Drafts: a QBI online seminar with Sagi Shapira

Mon Jan 11, 2021
Shapira.
The QBI online seminar series presents Dr. Sagi Shapira, an Assistant Professor in the Department of Systems Biology at Columbia University. Dr. Shapira completed a Master’s in Public Heath in Epidemiology of Infectious Diseases at Yale. He then completed his PhD at UPenn in immunology and...

Tejal Desai on refusing to take “no” for an answer

Mon Dec 28, 2020

New Chemical Strategies to Unravel Elusive Post-Translational Modifications: a QBI seminar with Rebecca Scheck

Thu Dec 17, 2020
Scheck.
The QBI online seminar series presents Rebecca Scheck, an Assistant Professor in the Department of Chemistry at Tufts University. She performed her graduate work with Prof. Matthew Francis at UC Berkeley, where she developed chemistry to modify proteins under mild conditions. In her postdoctoral...

Pages